-transparent.png){kind=logo}
Blood and other body f luids contain cell-derived microvesicles. The presence of microvesicles in cancer patients was already noticed in the late 1970s. Since then, the prothrombotic state in cancer patients has invariably been associated with the presence of such microvesicles. More recently, a growing body of evidence supports an important contribution of microvesicles to cancer cell survival, invasiveness and metastases. Here, we will present an overview of the many contributions of microvesicles to cancer development and progression. In addition, their role in risk stratification and treatment of cancer patients is discussed.
Related Publications
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
February 2012,
Comptes rendus biologies,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
January 2013,
Current molecular medicine,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
January 2024,
Biomaterials science,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
January 2013,
Current opinion in oncology,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
January 2012,
PloS one,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
June 2022,
Biomolecules,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
August 2012,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
January 2018,
Folia biologica,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
July 2015,
Cell biochemistry and function,
F F van Doormaal, and
A Kleinjan, and
M Di Nisio, and
H R Büller, and
R Nieuwland
December 2014,
Biomedical microdevices,
